Company: TXG
Filing Date: 2025-08-08
Form Type: 10-Q
Source: 0001770787-25-000051
Chunk: 37

Company: 10x Genomics, Inc.
Filing Date: 2025-08-08
Form: 10-Q
Item: Part I, Item 8
Chunk 37
---
 it will not have a material impact on the Company's financial condition and results of operations.

3.     Restructuring 

On May 6, 2025, the Company implemented a reduction in force plan in order to decrease costs and maintain a streamlined organization to support the business. Restructuring charges of $6.0 million associated with this plan, comprised primarily of severance-related costs, were recorded in the three and six months ended June 30, 2025.The following table is a summary of restructuring costs for the three and six months ended June 30, 2025 (in thousands):Severance and Benefits CostsStock-Based Compensation ExpenseTotalRestructuring charge$5,707 $314 $6,021 Cash payments made(3,005)— (3,005)Balance at June 30, 2025$2,702 $— $2,702 Restructuring costs of $0.4 million, $3.9 million and $1.7 million were recorded in cost of revenue, research and development expense, and selling, general and administrative expense, respectively, in the Company's condensed consolidated 

9

Table of Contents10x Genomics, Inc.Notes to Unaudited Condensed Consolidated Financial Statements

statements of operations during the three and six months ended June 30, 2025. The restructuring activities are expected to be substantially completed by the end of the third quarter of 2025.

4.    Other Financial Statement Information

Available-for-sale SecuritiesAvailable-for-sale securities consisted of the following (in thousands):June 30, 2025December 31, 2024Amortized CostGross Unrealized GainsGross Unrealized LossesFair Value Amortized CostGross Unrealized GainsGross Unrealized LossesFair ValueFair Value MeasurementCash equivalents: Money market funds$380,673 $— $— $380,673 $322,012 $— $— $322,012 Level 1Marketable securities: Government debt securities49,548 1 — 49,549 49,317 18 — 49,335 Level 2Total available-for-sale securities$430,221 $1 $— $430,222 $371,329 $18 $— $371,347 The contractual maturities of marketable securities as of June 30, 2025